Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
SHSE:600420'
s FCF Yield % Range Over the Past 10 Years
Min: -0.64 Med: 12.35 Max: 26.36
Current: 6.71
During the past 13 years, the highest FCF Yield % of Shanghai Shyndec Pharmaceutical Co was 26.36%. The lowest was -0.64%. And the median was 12.35%.
SHSE:600420's FCF Yield % is ranked better than 79.32% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 0.745
vs SHSE:600420: 6.71
Shanghai Shyndec Pharmaceutical Co FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Shanghai Shyndec Pharmaceutical Co FCF Yield % Related Terms
Shanghai Shyndec Pharmaceutical Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shyndec Pharmaceutical Co FCF Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Shyndec Pharmaceutical Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Shyndec Pharmaceutical Co FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Shyndec Pharmaceutical Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Shanghai Shyndec Pharmaceutical Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shyndec Pharmaceutical Co (SHSE:600420) has a FCF Yield % of 6.71 as of Jul. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Shanghai Shyndec Pharmaceutical Co and its competitors. This is 46% below median its historical median of 12.35. According to the industry distribution chart, Shanghai Shyndec Pharmaceutical Co ranks #208 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 20.7%.
Is Shanghai Shyndec Pharmaceutical Co's FCF Yield % too high?
Shanghai Shyndec Pharmaceutical Co's current FCF Yield % of 6.71 is 46% below median its 10-year median of 12.35. The Drug Manufacturers industry median FCF Yield % is 0.75. Shanghai Shyndec Pharmaceutical Co's value of 6.71 is 800.7% above this industry median. Based on the distribution chart, Shanghai Shyndec Pharmaceutical Co ranks #208 out of 1006 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Shyndec Pharmaceutical Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shyndec Pharmaceutical Co's FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai Shyndec Pharmaceutical Co ranks #208 out of 1006 companies for FCF Yield %. This places Shanghai Shyndec Pharmaceutical Co in the top 21% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.75. Shanghai Shyndec Pharmaceutical Co's value of 6.71 is 800.7% above this benchmark. While the company's 10-year median is 12.35 vs. the industry median of 0.75, Shanghai Shyndec Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.75, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Shyndec Pharmaceutical Co's current FCF Yield % of 6.71 is 800.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Shanghai Shyndec Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Shyndec Pharmaceutical Co's current FCF Yield % is 6.71, which is 46% below median its own 10-year median of 12.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shyndec Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shyndec Pharmaceutical Co (SHSE:600420) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥11.08, compared to a current price of ¥8.47 — trading 23.6% below its estimated fair value. The current FCF Yield % is 6.71, which is 46% below median its 10-year median of 12.35 and 800.7% above the Drug Manufacturers industry median of 0.75. Shanghai Shyndec Pharmaceutical Co's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Shanghai Shyndec Pharmaceutical Co (SHSE:600420), the current FCF Yield % is 6.71 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Shyndec Pharmaceutical Co (SHSE:600420) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Shyndec Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥8.47 is trading 23.6% below its estimated GF Value™ of ¥11.08.
GuruFocus considers Shanghai Shyndec Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for SHSE:600420:
FCF Yield %: 6.71 (46% below median its 10-year median of 12.35)
GF Value™: ¥11.08 vs. price of ¥8.47 (23.6% below fair value)
Industry Position: 800.7% above the Drug Manufacturers median (#208 of 1006)
No single metric tells the full story. See the SHSE:600420 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Shyndec Pharmaceutical Co Business Description
Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.
60GF Score
Get the complete analysis for SHSE:600420
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600420 has been successfully added to your 
